RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,589,000 | -4.1% | 1,346,904 | -8.2% | 0.41% | +10.5% |
| Q2 2022 | $1,657,000 | -62.2% | 1,466,678 | 0.0% | 0.37% | -61.1% |
| Q1 2022 | $4,385,000 | +12.6% | 1,466,678 | -0.2% | 0.95% | +4.2% |
| Q4 2021 | $3,894,000 | -39.5% | 1,469,604 | -17.1% | 0.92% | -28.7% |
| Q3 2021 | $6,435,000 | -13.1% | 1,772,730 | +3.9% | 1.28% | -2.1% |
| Q2 2021 | $7,402,000 | +41.4% | 1,705,553 | +11.4% | 1.31% | +36.7% |
| Q1 2021 | $5,234,000 | -6.5% | 1,530,490 | -4.3% | 0.96% | -10.0% |
| Q4 2020 | $5,595,000 | +70.7% | 1,598,649 | +17.1% | 1.06% | +42.8% |
| Q3 2020 | $3,277,000 | – | 1,365,286 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,550,000 | $14,606,000 | 4.17% |
| Sio Capital Management, LLC | 1,843,501 | $5,918,000 | 2.03% |
| Sofinnova Investments, Inc. | 3,260,931 | $10,467,000 | 0.93% |
| Boxer Capital, LLC | 2,321,900 | $7,453,000 | 0.83% |
| Rhenman & Partners Asset Management AB | 2,113,988 | $6,786,000 | 0.68% |
| Palo Alto Investors LP | 3,966,087 | $12,731,000 | 0.52% |
| Rock Springs Capital Management LP | 4,125,000 | $13,241,000 | 0.48% |
| NEA Management Company, LLC | 3,243,150 | $10,411,000 | 0.45% |
| B. Riley Financial, Inc. | 473,343 | $1,519,000 | 0.43% |
| Walleye Capital LLC | 151,923 | $488,000 | 0.23% |